Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
Clinical trial NCT05405192 · WITHDRAWN
Trial details
- NCT number
- NCT05405192
- Sponsor
- University of Miami
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2026-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.